Navigation Links
Cancers with disorganized 'traffic systems' more difficult to treat: U of A research
Date:6/21/2012

Medical researchers at the University of Alberta reviewed test results from thousands of patients with various types of cancer and discovered that "disorganized" cancers were more difficult to treat and consistently resulted in lower survival rates.

Principal investigator Jack Tuszynski says physicians could use a mathematical equation, or algorithm, to determine how disorganized their patients' cancer is. Once physicians determine that, then they could pinpoint which cancer treatment would be the most effective. Some cancer drugs are effective at treating simple cancers, while others are designed to attack complex cancers.

The current emphasis in cancer treatment is to inhibit "traffic systems" in cancer, says the researcher.

"Using a math equation, doctors could predict if a given therapy will be successful, which would spare the patient from suffering," says Tuszynski, who holds the Alberta Cancer Foundation-funded Allard Research Chair in Oncology with the Faculty of Medicine & Dentistry at the University of Alberta. "Instead of spending millions of dollars on clinical trials to find better cancer drugs, algorithms could be used to better pinpoint treatment instead."

The research conducted by Tuszynski, a summer student, and research colleagues in Boston, was recently published in the peer-reviewed journal Proceedings of the National Academy of Sciences (PNAS). The group looked at 14 types of cancer, including those with high survivability, like prostate cancer, and those with high death rates, such as pancreatic cancer. Each type of cancer has its own unique "metro map," says Tuszynski.

"These traffic signalling systems inside cancer cells look like transportation hubs or metro maps, so you can measure how many stations and how many lines you have," says Tuszynski, who has a joint appointment in the Department of Oncology, as well as the Department of Physics in the Faculty of Science.

"The surprising part is, the more disorganized the traffic signalling system, the more robust and stubborn the cancer is against chemotherapy. If cancer cells have a complex metro map with lots of branches at various locations, then the cancer is very hard to paralyze.

"This research discovery has given us a glimpse into an important issue in cancer treatment. The finding is very telling."

The Alberta Cancer Foundation, which funded the research, is excited about the discovery.

"Dr. Tuszynski's work in computational biophysics promises to create more personalized treatment for cancer patients by targeting the cancerous cells while reducing side effects to healthy cells," says Myka Osinchuk, CEO of the Alberta Cancer Foundation. "This latest research discovery will help push the pace of discovery and we are excited to hear more about the progress being made in this area."

Tuszynski is continuing his research in this area and expects to soon publish more related findings.


'/>"/>

Contact: Raquel Maurier
raquel.maurier@ualberta.ca
780-492-5986
University of Alberta Faculty of Medicine & Dentistry
Source:Eurekalert

Related medicine news :

1. HPV-Related Head, Neck Cancers on the Rise
2. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
3. Kinase test may yield big gains for drug-resistant cancers
4. Vitamin E in diet protects against many cancers
5. Infection Causes 1 in 6 Cancers Worldwide: Study
6. Fertilizing bone marrow helps answer why some cancers spread to bones
7. Experimental Drug Helps Fight Some Childhood Cancers, Study Finds
8. Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers
9. Discovery suggests new combination therapy strategy for basal-like breast cancers
10. Moffitt researcher, colleagues find success with new immune approach to fighting some cancers
11. Gum Disease, HPV May Play Role in Head & Neck Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... Massachusetts (PRWEB) , ... September ... ... , a software company specializing in medical device compliance and commercialization, has ... in risk management activities. , FDA is more adamant than ever about ...
(Date:9/20/2017)... ... , ... Compliancy Group is proud to announce that its ... another long-time client pass their Department of Health and Human Services (HHS) Office ... to the help of the Compliancy Group's Audit Response Program™, not a single ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... The Centers ... 2018 Final Rule that it will transition to using only Worksheet S-10 to distribute ... the first of three live 60-minute complimentary webinars on October 17, 2017 ...
(Date:9/20/2017)... ... September 20, 2017 , ... “RECYCLED ... “RECYCLED Ezekiel's Plan for Freedom from ADDICTION” is the creation of published author, ... field of addiction and homeless services, including more than a decade of addiction ...
(Date:9/20/2017)... ... ... Road to Moorwick”: the adventures of a young Scottish girl yearning to see the world. ... busy mother of five who used her time waiting for children to finish their extracurricular ... years. It was a way to give some meaning to the hours I waited ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 8, 2017 Dealmed Medical Supplies, ... medical equipment, supplies, drugs, vaccines, and specialty medical products ... an agreement to acquire Vantage Medical Supplies, a major ... Holtsville, New York . ... and emerging medical practices, will operate under the Dealmed ...
(Date:9/7/2017)... 7, 2017  Eli Lilly and Company (NYSE: ... streamline operations to more efficiently focus resources on ... structure. Global workforce reductions, including those from a ... impact approximately 3,500 positions. With ... savings of approximately $500 million that will begin ...
(Date:9/7/2017)... Texas , Sept. 7, 2017 ... science focused on fulfilling the promise of precision ... further validate the benefits of its molecular profiling ... study utilized comprehensive genomic profiling plus (CGP+) with ... individual patient,s tumor on a molecular level, leading ...
Breaking Medicine Technology: